Equity Investment


This product is specifically designed for promising and innovative entities that require patient capital to scale up, and for which debt finance is either unattainable or not suitable. The Bank invests by taking up shareholding in qualifying entities and divesting after a given time. The entity is allowed to involve other private capital providers where feasible.

Key feature

The product targets entities with high growth potential and/or socio-economic impact at pre-revenue, early growth, or growth stage, but deemed unsuitable for conventional debt finance.


UDB will be a shareholder for a maximum of 10 years.